SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-22-087884
Filing Date
2022-08-09
Accepted
2022-08-09 16:01:46
Documents
1
Period of Report
2022-06-30
Effectiveness Date
2022-08-09

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tm2222805d1_nt10q.htm NT 10-Q 19266
  Complete submission text file 0001104659-22-087884.txt   20400
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 221148082
SIC: 2836 Biological Products, (No Diagnostic Substances)